- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT02667366
Effectiveness and Cost-effectiveness of Telephone-delivered Psychotherapy for Depression in Primary Care
Improving Access to Evidence-based Treatment for Depression: Effectiveness and Cost-effectiveness of Telephone-delivered Cognitive Behavioral Therapy (CBT) in Primary Care
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
The overall purpose of the study is to examine the effectiveness of telephone psychotherapy (Tel-PT) for the treatment of mild to moderate depression on different outcome-levels and under clinically representative conditions in Swiss primary health care. The randomized-controlled trial (RCT) will evaluate the primary hypothesis that Tel-PT is more effective than routine primary care (i.e. treatment as usual, TAU), more specifically, that it leads to significant higher reduction in depression severity than TAU at follow-up.
The intervention group (IG) receives a manualized short-term cognitive behavioral treatment, which is the adapted German version of the program "Creating a balance" developed in the USA. The therapy consists of one face-to-face and 8-12 telephone contacts and is carried out by a licensed psychotherapist.
More concrete, recruitment and inclusion of the patients will be carried out by the participating general practitioners (GPs). GPs will be instructed to screen patients at risk for depression, especially those revealing diffuse somatic symptoms and suffering from chronic diseases. If positively screened, patient's depressive symptoms are assessed with Patient Health Questionnaire (PHQ-9) and diagnosed according to ICD-10.
All GPs will receive an initial training prior to their participation, providing them with study information and procedures as well as training in screening procedure, psychodiagnostics and study enrolment.
Eligible patients are provided with detailed study information and asked to participate. Subsequently, patients will give informed consent. Patients will then be included into the study and fill out the baseline questionnaires (t0). After that, randomization will be carried out at the University of Zurich, based on an appropriately created computer algorithm. Both GPs and patients are informed about the results by the study team within two days. Subsequently, patients in control group (CG) will receive regular text messages and patients in the intervention group (IG) will be called by the study therapist to schedule an initial appointment.
In case of positive results, the overarching objective is the optimization of mental health services for depressed patients by implementing an evidence-based, accessible and cost-effective treatment option into primary care.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Zurich, Schweiz, 8050
- University of Zurich
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- PHQ-9 score of > 5 and ≤15.
- Informed Consent as documented by signature (Appendix Informed Consent Form)
- Minimum age of 18 years
- Diagnosis of mild to moderate depression according to ICD-10 (F32.0, F32.1, F33.0, F33.1)
Exclusion Criteria:
- Patients currently being in psychotherapeutic treatment or treatment in past three months
- Suicidal tendencies or suicidality
- Insufficient knowledge of German language
- Health condition that does not allow questionnaire completion
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: Tel-PT
Tel-PT receives a manualized short-term CBT.
Treatment consists of one initial face-to-face appointment and 8-12 subsequent telephone sessions between patient and licensed therapist.
Each telephone contact lasts between 20 and 30 minutes and take place on a weekly and later biweekly basis.
|
|
Aktiver Komparator: TAU and text messages
Control Group receives treatment as usual and additionally weekly text messages containing general information about depression.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Change in depressive symptoms
Zeitfenster: t0 (baseline) and t2 (12 months after baseline)
|
The change in depressive symptoms will be assessed with the German version of Patient Health Questionnaire (PHQ-9; Löwe, Spitzer, Zipfel, & Herzog 2002).
|
t0 (baseline) and t2 (12 months after baseline)
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Change in depressive symptoms
Zeitfenster: t0 (baseline) and t1 (four months after baseline)
|
The change in depressive symptoms will be assessed with the German version of Patient Health Questionnaire (PHQ-9; Löwe, Spitzer, Zipfel, & Herzog 2002).
|
t0 (baseline) and t1 (four months after baseline)
|
Response
Zeitfenster: t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
Response defined as 50% reduction in the PHQ-9.
|
t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
Change in health-related quality of life
Zeitfenster: t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
Change in health-related quality of life is measured with the 12-Item Short Form Health Survey (SF-12; Bullinger & Kirchberger, 1998).
|
t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
Self-efficacy for management and relapse prevention in depression
Zeitfenster: t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
Depression self-efficacy scale for management and relapse prevention (Bush et al., 2001).
|
t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
Cost-effectiveness
Zeitfenster: t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
Health care utilization and productivity loss will be measured with an adapted version of the Client Sociodemographic and Service Receipt Inventory (CSSRI; Chisholm et al., 2000).
For Switzerland, country-specific unit costs will be employed to calculate direct and indirect costs.
|
t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
Cost-effectiveness
Zeitfenster: t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
Health-related quality of life for the economic analyses will be measured using the EQ-5D-5L (The EuroQuol Group, 1990), Quality-adjusted life years (QALYs) based on the EQ-5D index will be determined and the incremental cost-effectiveness ratio (ICER) will be computed.
|
t0 (baseline), t1 (four months after baseline), t2 (12 months after baseline)
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Acceptance and satisfaction with the intervention
Zeitfenster: t1 (four months after baseline)
|
Patients' and therapists' acceptance and satisfaction with the intervention will be assessed by a self-constructed questionnaire.
|
t1 (four months after baseline)
|
Process and structural variable
Zeitfenster: t1 (four months after baseline), t2 (12 months after baseline)
|
Mean duration of telephone contacts
|
t1 (four months after baseline), t2 (12 months after baseline)
|
Process and structural variable
Zeitfenster: t1 (four months after baseline), t2 (12 months after baseline)
|
Mean number of telephone contacts.
|
t1 (four months after baseline), t2 (12 months after baseline)
|
Process and structural variable
Zeitfenster: t1 (four months after baseline), t2 (12 months after baseline)
|
Dropout rate
|
t1 (four months after baseline), t2 (12 months after baseline)
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Birgit Watzke, Prof, University of Zurich, Department of Clinical Psychology and Psychotherapy Research
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Simon GE, Ludman EJ, Tutty S, Operskalski B, Von Korff M. Telephone psychotherapy and telephone care management for primary care patients starting antidepressant treatment: a randomized controlled trial. JAMA. 2004 Aug 25;292(8):935-42. doi: 10.1001/jama.292.8.935.
- Löwe, B, Spitzer, RL, Zipfel, S, & Herzog, W. Gesundheitsfragebogen für Patienten (PHQ-D): Manual und Testunterlagen. Pfizer. Karlsruhe: 2002.
- Watzke B, Heddaeus D, Steinmann M, Konig HH, Wegscheider K, Schulz H, Harter M. Effectiveness and cost-effectiveness of a guideline-based stepped care model for patients with depression: study protocol of a cluster-randomized controlled trial in routine care. BMC Psychiatry. 2014 Aug 20;14:230. doi: 10.1186/s12888-014-0230-y.
- Bush, T, Russo, J, Ludman, E, Lin, E, Von Korff, M, Simon, G, Walker, E. Perceived self-efficacy for depression self-management. A reliable and valid self-report measure with predictive validity: Poster presentation at the American Psychological Society Meeting, June 2001. Toronto, Canada.
- Bullinger, M, & Kirchberger, I. Fragebogen zum Gesundheitszustand. Hogrefe. Göttingen: 1998.
- Haller E, Besson N, Watzke B. "Unrigging the support wheels" - A qualitative study on patients' experiences with and perspectives on low-intensity CBT. BMC Health Serv Res. 2019 Oct 9;19(1):686. doi: 10.1186/s12913-019-4495-1.
- Watzke B, Haller E, Steinmann M, Heddaeus D, Harter M, Konig HH, Wegscheider K, Rosemann T. Effectiveness and cost-effectiveness of telephone-based cognitive-behavioural therapy in primary care: study protocol of TIDe - telephone intervention for depression. BMC Psychiatry. 2017 Jul 19;17(1):263. doi: 10.1186/s12888-017-1429-5.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Voraussichtlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- BW-0417
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Depression
-
Washington University School of MedicineAbgeschlossenBehandlungsresistente Depression | Altersdepression | Altersdepression | Refraktäre Depression | Therapieresistente DepressionVereinigte Staaten, Kanada
-
Brigham and Women's HospitalRekrutierungDepression | Bipolare Störung | Bipolare Depression | Episode einer Major Depression | Bipolare I-Depression | Bipolare II-DepressionVereinigte Staaten
-
Ludwig-Maximilians - University of MunichAbgeschlossenTherapieresistente Major DepressionDeutschland
-
Stony Brook UniversityRekrutierungDepression; DepressionVereinigte Staaten
-
St Patrick's Hospital, IrelandAbgeschlossenBipolare Depression | Unipolare Depression | Episode einer Major DepressionIrland
-
University Health Network, TorontoAbgeschlossenBipolare Störung | Bipolare Depression | Bipolare I-Depression | Bipolare II-DepressionKanada
-
University of Dublin, Trinity CollegeRekrutierungBipolare Depression | Unipolare Depression | Episode einer Major DepressionIrland
-
Baylor College of MedicineIcahn School of Medicine at Mount SinaiAbgeschlossenMajor Depression (MDD) | Behandlungsresistente Depression (TRD)Vereinigte Staaten
-
Paul J. LamotheUnbekanntBehandlungsresistente Depression | Depression,Mexiko
-
Soterix MedicalNYU Langone HealthAbgeschlossenBehandlungsresistente Depression | Unipolare DepressionVereinigte Staaten
Klinische Studien zur Tel-PT
-
Universitätsklinikum Hamburg-EppendorfAbgeschlossen
-
University of California, San FranciscoNational Institute of Mental Health (NIMH)AbgeschlossenHIV | MedikamentenhaftungIndien
-
Yale UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...AbgeschlossenKongestive HerzinsuffizienzVereinigte Staaten
-
Rigshospitalet, DenmarkLundbeck FoundationAbgeschlossen
-
Chang Gung Memorial HospitalMinistry of Science and Technology, TaiwanAbgeschlossenMedizinische Ausbildung
-
Vanderbilt University Medical CenterUnited States Department of DefenseRekrutierungDegeneration der Halswirbelsäule | ACDF-ChirurgieVereinigte Staaten
-
Promontory Therapeutics Inc.Aktiv, nicht rekrutierendUrogenitale Neoplasmen | Neubildungen nach Standort | Genitale Neubildungen, männlich | Prostataneoplasmen | Fortgeschrittene solide Tumoren | mCRPC | Metastasierter kastrationsresistenter Prostatakrebs | CRPC | PT-112Vereinigte Staaten, Frankreich
-
Riphah International UniversityAbgeschlossenOBERES KREUZ-SYNDROMPakistan
-
Alabama Physical Therapy & AcupunctureUniversidad Rey Juan CarlosAbgeschlossenPlantarfasziitisVereinigte Staaten
-
Alabama Physical Therapy & AcupunctureUniversidad Rey Juan CarlosAbgeschlossenKnie ArthroseVereinigte Staaten